CVI Holdings’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

CVI Holdings’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$5K	–	919
2022 Q2	$5K	Hold	50,000	–	–	﹤0.01%	840
2022 Q1	$22K	Hold	50,000	–	–	﹤0.01%	765
2021 Q4	$20K	Hold	50,000	–	–	﹤0.01%	882
2021 Q3	$33K	Hold	50,000	–	–	﹤0.01%	811
2021 Q2	$80K	Buy	+50,000	New	+$81.7K	0.01%	637

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CVI Holdings's APGNW Position: Q3 2022 in Review

CVI Holdings sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2022, closing a stake of 50,000 shares — an estimated $5K sold.

CVI Holdings first reported a position in APGNW in Q2 2021 and held it in 5 quarters. The position peaked at $80K in Q2 2021. 16 funds tracked by Wall St. Rank hold APGNW as of Q3 2022.

CVI Holdings reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
CVI Holdings sold 50,000 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2022, an estimated $5K.
CVI Holdings first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q2 2021 and held it in 5 quarters.
CVI Holdings's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $80K in Q2 2021.
16 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2022.

Based on CVI Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.